✦ LIBER ✦

Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP

✍ Scribed by Josep-Maria Ribera; Mireia Morgades; Eva González-Barca; Pilar Miralles; Armando López-Guillermo; Santiago Gardella; Andres López; Eugenia Abella; Marta García; Jose-Tomas Navarro; Evarist Feliu

Book ID: 114714632
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 97 KB
Volume: 157
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09046.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicentre phase II study of CyclOBEAP

Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma

✍ Nozomi Niitsu; Mika Kohri; Yuki Hagiwara; Ken Tanae; Naoki Takahashi; Masami Bes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract The R‐CHOP regimen has been found to improve the outcome of diffuse large B‐cell lymphoma (DLBCL). However, it does not provide a satisfactory treatment outcome in the high‐risk group. We previously administered the CyclOBEAP regimen to patients with DLBCL, and reported its safety and e

Prognostic Significance of Survivin and

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

✍ Zdravko Mitrović; Ivana Ilić; Igor Aurer; Sandra Bašić Kinda; Ivo Radman; Snježa 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 308 KB

CHOP chemotherapy followed by Rituximab

CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial

✍ Gerald Jäger; Franz Quehenberger; Werner Linkesch; Peter Neumeister 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB

Lack of prognostic significance of the g

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab

✍ Ivana Ilić; Zdravko Mitrović; Igor Aurer; Sandra Bašić-Kinda; Ivo Radman; Radmil 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 268 KB

The expression of 16 genes related to th

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab

✍ Jais, J-P; Haioun, C; Molina, T J; Rickman, D S; de Reynies, A; Berger, F; Gisse 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Phase II study of the CPT-11, mitoxantro

Phase II study of the CPT-11, mitoxantrone and dexamethasone regimen in combination with rituximab in elderly patients with relapsed diffuse large B-cell lymphoma

✍ Nozomi Niitsu; Mika Kohuri; Masaaki Higashihara; Masami Bessho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB